OriGen Biomedical, Inc. Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl Olefin (EVO) and contains no BPA or latex. The bag can be supplied with tubing sets that can include, but are not limited to, the following components: EVA/PVC coextruded tubing, PVC tubing, Yconnectors, needle-free valves, female luers, male luers and/or caps Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl Olefin (EVO) and contains no BPA or latex. The bag can be supplied with tubing sets that can include, but are not limited to, the following components: EVA/PVC coextruded tubing, PVC tubing, Yconnectors, needle-free valves, female luers, male luers and/or caps
Brand
OriGen Biomedical, Inc.
Lot Codes / Batch Numbers
All Lots
Products Sold
All Lots
OriGen Biomedical, Inc. is recalling Evolve Cell Culture Bags, part numbers: EV1000N and EV3000N The Evolve bag is made of Ethyl Vinyl due to It was identified that tissue culture bags were incorrectly labeled as free of phthalates.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
It was identified that tissue culture bags were incorrectly labeled as free of phthalates.
Recommended Action
Per FDA guidance
On 01/28/2021, Origen Biomedical, Inc. sent an "Technical Bulletin" via email to all affected consignees. On 4/12/21, the firm followed up a "Urgent: Medical Device Removal notification issued via E-Mail. In addition to informing consignees about the recall and technical bulletin, the The technical bulletin informed consignees about the following items: 1. Identify and quarantine any devices from the lots listed in this notice. 2. If affected product per Table 1 is identified, complete OriGens Material Return Authorization form (RD36), attached as Annex I to this notice. a. Leave the RMA # (assigned by OriGen to Customer) blank b. In Reason for Return: section, please write FA_2020_001 3. Send the RD36 form to OriGen Customer Service (info@origenbio.com). OriGen Customer Service will provide a return label, an RMA# to enter on the RD36 form, and will issue a credit for the product. 4. Appropriately package the rejected product and return to OriGen using the supplied return label. 5. Please complete the Field Action Customer Reply Form attached as Annex II to this notice, scan and send to OriGen Customer Service (info@origenbio.com). Please complete this form even if you do not have any affected product. 6. This information and instruction must be passed on to all those who need to be aware within your organization or to any organization where the potentially affected devices have been transferred and remain unused. 7. If you should have any questions or concerns regarding this field notice, please contact Richard Martin, Recall Coordinator, at d.martin@origenbio.com or at 512-474-7278. 8. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, CT, FL, IL, IA, KS, LA, MD, MA, NJ, NY, NC, OH, OR, PA, RI, TN, TX, PR
Page updated: Jan 10, 2026